Quarterly report · Q2
4320.TEDINET S100QQ1L
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥13.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.2bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥840m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥616m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥838m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥861m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥621m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥495m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥588m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥336m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥536m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥378m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥11.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥10.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥11.4bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.1bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥289m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥254m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥764m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥891m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥194m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥307m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥535m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥32.99 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.13 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.38 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.85 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥26m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥873m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥8m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥865m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥60m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥681m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥19m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥5m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥7.2bn |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥676m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest expenses ope cf | Prior1YTDDuration | 3291000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 3642000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -216501000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -1149674000 | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | Prior1YTDDuration | － | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | CurrentYTDDuration | 46119000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 483785000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 102258000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 722007000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -71196000 | JPY |
| Other net ope cf | Prior1YTDDuration | -32737000 | JPY |
| Other net ope cf | CurrentYTDDuration | 84868000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 1737597000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 29597000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1330000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1404000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3291000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -3642000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -297924000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -368417000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 38458000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 52163000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 1476170000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -288894000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -844668000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -38149000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -185671000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -185288000 | JPY |
| Proceeds from sales of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | 400000000 | JPY |
| Proceeds from sales of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | － | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -4900000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -700000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 9511000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 9483000 | JPY |
| Proceeds from share of profits on investments in partnership | Prior1YTDDuration | 3961000 | JPY |
| Proceeds from share of profits on investments in partnership | CurrentYTDDuration | 1572000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | -265425000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | － | JPY |
| Other net inv cf | Prior1YTDDuration | -3878000 | JPY |
| Other net inv cf | CurrentYTDDuration | -41011000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -891070000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -254093000 | JPY |
| Increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Increase decrease in short term loans payable fin cf | CurrentYTDDuration | 390000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 1000000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -326197000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -297555000 | JPY |
| Redemption of bonds fin cf | Prior1YTDDuration | -20000000 | JPY |
| Redemption of bonds fin cf | CurrentYTDDuration | -5000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |